The hepatitis B vaccine is one of the most potent immunizations, usually providing decades of protection against the deadly liver virus. But in about 10% of people it doesn’t work, and in 2020, Amy Huei-Yi Lee, a systems biologist at Simon Fraser University, and her colleagues set out to determine whether they could predict who would benefit. The scientists found that data on recipients’ immune systems such as the abundance of certain proteins and the activity patterns of a few genes foretold whether they would generate defenses against the virus. “We got a sense of what factors drive the vaccine response and what [doesn’t],” Lee says.
Trending
- CBN clearing airline debts to boost Nigeria–UK aviation ties — Tinubu
- [VIEWPOINT] Why Adeyanju earns 90% approval in Ondo North senate poll, By Bashir Adefaka
- NMA suspends national president
- Sightsavers trains health workers in sign language
- Youth protest INEC leadership in Sokoto
- Breast cancer care training held in Abuja
- Shettima inaugurates Kano grain facility
- Lawmakers back post-harvest innovation
